Loading fund overlap…
22 of 52 unique stocks in common · Jaccard: 42.3%
A weighted portfolio overlap of 52.88% indicates a moderate overlap (a meaningful shared core). This means that out of every ₹100 you invest across these two schemes, approximately ₹52.88 is allocated to the exact same companies at the same relative proportions. The schemes share 22 common holdings.
The largest overlapping asset in their portfolios is Sun Pharmaceutical Industries, which commands a weight of 11.03% in SBI Healthcare Opportunities Fund and 8.87% in UTI - Healthcare Fund. Holding both schemes increases your concentration in Sun Pharmaceutical Industries rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in SBI | in UTI |
|---|---|---|
| Sun Pharmaceutical IndustriesPharmaceuticals & Biotechnology | 11.03% | 8.87% |
| Divi's LaboratoriesPharmaceuticals & Biotechnology | 6.57% | 4.87% |
| Apollo Hospitals EnterpriseHealthcare Services | 5.37% | 3.56% |
| Fortis HealthcareHealthcare Services | 3.05% | 3.05% |
| Gland PharmaPharmaceuticals & Biotechnology | 2.96% | 3.98% |
| Max Healthcare InstituteHealthcare Services | 4.76% | 2.74% |
| Anthem BiosciencesPharmaceuticals & Biotechnology | 3.00% | 2.33% |
| Sai Life SciencesPharmaceuticals & Biotechnology | 2.54% | 2.19% |
| Alkem LaboratoriesPharmaceuticals & Biotechnology | 2.11% | 3.07% |
| LupinPharmaceuticals & Biotechnology | 1.99% | 3.80% |
| Jupiter Life Line HospitalsHealthcare Services | 2.62% | 1.97% |
| Aster DM HealthcareHealthcare Services | 3.83% | 1.94% |
| Ajanta PharmaPharmaceuticals & Biotechnology | 1.92% | 4.70% |
| Aurobindo PharmaPharmaceuticals & Biotechnology | 3.90% | 1.88% |
| CiplaPharmaceuticals & Biotechnology | 1.84% | 1.73% |
| Sudeep PharmaChemicals & Petrochemicals | 2.21% | 1.72% |
| Cohance LifesciencesPharmaceuticals & Biotechnology | 1.70% | 2.48% |
| Global HealthHealthcare Services | 1.46% | 2.25% |
| Krishna Institute Of Medical SciencesHealthcare Services | 1.99% | 1.44% |
| Rainbow Childrens MedicareHealthcare Services | 0.91% | 1.64% |
| Dr. Lal Path LabsHealthcare Services | 0.84% | 1.32% |
| BioconPharmaceuticals & Biotechnology | 3.52% | 0.70% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on May 2026). Equity holdings only, ISIN-verified. Not investment advice.